Skip to content

Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy

Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02900833
Acronym
NEUTROSTROKE
Enrollment
440
Registered
2016-09-14
Start date
2016-03-24
Completion date
2026-06-19
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke

Brief summary

Clinical and experimental data suggest that neutrophil activation and extravasation are deleterious in acute ischemic stroke (AIS) involving an increased risk of unfavorable outcome and hemorrhagic transformation (HT). However, clinical trials targeting neutrophil recruitment in AIS patients were negative. Recently, an experimental study has shown that neutrophil activation and transmigration begin immediately after the occlusion. Inhibition of neutrophil recruitment several hours after the start of ischemia appears therefore too late to have a clinical relevance. The objective is to study the time dependent impact of neutrophils in AIS and the predominant mediators in each time point to identify the appropriate therapeutic target and time window.

Interventions

None listed

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>= 18 years old * acute ischemic stroke secondary to a large vessel occlusion. * Patients hospitalized for endovascular therapy.

Exclusion criteria

* Pregnant or breast feeding patient * patient under legal protection * Patient opposition to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
neutrophil countsbefore recanalizationPlasma neutrophil activation bio-markers
neutrophil protease countsbefore recanalization
recanalization scoreimmediately after endovascular procedureThrombolysis in Cerebral Infarction classification (TICI)
acute ischemic stroke etiologywithin 24 hours after endovascular procedureas defined by the Trial of Danaparoid (ORG10172) in Acute Stroke Treatment (TOAST classification)
severity of neurologic symptomsbaselineNational Institutes of Health Stroke Scale (NIHSS)
disruption of the blood-brain-barrierwithin 24 hours after endovascular procedurediagnosis on cerebral Computerized Tomography
brain haemorrhage24 hours after endovascular procedureNational Institutes of Health Stroke Scale (NIHSS)
Recovery of motor function after stroke3 monthsmodified Rankin scale
mortality3 months
adhesion molecules countsbefore recanalization
free plasma DNA countsbefore recanalization

Countries

France

Contacts

PRINCIPAL_INVESTIGATORJean-Philippe DESILLES, MD

Fondation OPH A de Rothschild

STUDY_CHAIRMikael MAZIGHI, MD, PhD

Fondation OPH A de Rothschild

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026